Emergent Biosolutions EBS Interest Paid
Interest Paid at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:InterestPaidNet.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's interest paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's interest paid?
- Emergent Biosolutions (EBS) reported interest paid of $13.1M in Q1 2026.
- How has Emergent Biosolutions's interest paid changed year-over-year?
- Emergent Biosolutions's interest paid decreased by 21.6% year-over-year, from $16.7M to $13.1M.
- What is the long-term trend for Emergent Biosolutions's interest paid?
- Over 4 years (2021 to 2025), Emergent Biosolutions's interest paid has grown at a 13.1% compound annual growth rate (CAGR), from $30.4M to $49.7M.
- What does interest paid mean?
- Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.